Selenium-containing histone deacetylase inhibitors for melanoma management.
about
Identifying the structure-activity relationship of leelamine necessary for inhibiting intracellular cholesterol transport.Leelamine mediates cancer cell death through inhibition of intracellular cholesterol transport.Targeting multiple key signaling pathways in melanoma using leelamine.Histone deacetylase inhibitors induce invasion of human melanoma cells in vitro via differential regulation of N-cadherin expression and RhoA activity.Epigenetic effects of selenium and their implications for healthSimultaneous targeting of COX-2 and AKT using selenocoxib-1-GSH to inhibit melanomaHistone deacetylase enzymes as drug targets for the control of the sheep blowfly, Lucilia cuprinaCombination of fenretinide and selenite inhibits proliferation and induces apoptosis in ovarian cancer cells.Post SELECT: selenium on trial.Nanoparticle-Based Celecoxib and Plumbagin for the Synergistic Treatment of Melanoma.Eradication of metastatic melanoma through cooperative expression of RNA-based HDAC1 inhibitor and p73 by oncolytic adenovirus.Inhibition of histone deacetylases in melanoma-a perspective from bench to bedside.Targeting protein kinase-b3 (akt3) signaling in melanoma.Class II-specific histone deacetylase inhibitors MC1568 and MC1575 suppress IL-8 expression in human melanoma cells.A Summary of New Findings on the Biological Effects of Selenium in Selected Animal Species-A Critical Review.Nanoliposomal delivery of cytosolic phospholipase A2 inhibitor arachidonyl trimethyl ketone for melanoma treatment.Tricaproin Isolated From Simarouba glauca Inhibits the Growth of Human Colorectal Carcinoma Cell Lines by Targeting Class-1 Histone Deacetylases.Selenium at the redox interface of the genome, metabolome and exposome
P2860
Q33709666-34FF25AC-C22D-45BC-A901-3CB76B8831E5Q34413011-7741643C-C83A-4813-9FAC-4C33735C5274Q35136450-EBCB75D9-F15D-4D7D-AA0A-28A30C77ECECQ36109506-3ECA41CD-5389-449B-87EE-76EEE3BE8975Q36216208-2AE5C58E-D9CF-4858-A586-9DDCE86AC4A0Q36536476-D442E5FB-2F79-4AD2-ACC9-B5291365D009Q36841513-BD11A03C-4F57-48FA-8174-BB7B8DDF4AE3Q37375377-1EC98FF6-4E3E-4255-B96E-F54B82CCBFFBQ38077547-4747B6C8-8E1D-4B63-BCA2-3AF53A3C9C90Q38724921-1D0F1E3B-6368-4578-B7F4-D57AAF036012Q38970754-EAFC0C46-4E83-416F-A780-226A0412E763Q38993736-A78C4FDE-5978-41AD-90AC-9E94F66D1AACQ39074281-D35EA0BE-C121-48BB-A066-D57DA1022A5DQ39240051-3D1B5538-22A2-4253-BF97-CBD6FB9D7D05Q44481320-1E6D8915-C402-43C3-BD4D-E47596EA7DC4Q50113740-19AF76DF-0971-41F4-BD05-EFEC5305FF7DQ55259949-582C445F-B7D9-4EC4-999D-AD1540E6DF8AQ58076433-7ABC4116-F24E-489C-B8A1-A00942A71356
P2860
Selenium-containing histone deacetylase inhibitors for melanoma management.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Selenium-containing histone deacetylase inhibitors for melanoma management.
@en
Selenium-containing histone deacetylase inhibitors for melanoma management.
@nl
type
label
Selenium-containing histone deacetylase inhibitors for melanoma management.
@en
Selenium-containing histone deacetylase inhibitors for melanoma management.
@nl
prefLabel
Selenium-containing histone deacetylase inhibitors for melanoma management.
@en
Selenium-containing histone deacetylase inhibitors for melanoma management.
@nl
P2093
P2860
P356
P1476
Selenium-containing histone deacetylase inhibitors for melanoma management.
@en
P2093
Dhimant Desai
Gavin P Robertson
Raghavendra Gowda
Shantu Amin
Subbarao V Madhunapantula
P2860
P304
P356
10.4161/CBT.20558
P577
2012-06-06T00:00:00Z